JP2009526795A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526795A5
JP2009526795A5 JP2008554655A JP2008554655A JP2009526795A5 JP 2009526795 A5 JP2009526795 A5 JP 2009526795A5 JP 2008554655 A JP2008554655 A JP 2008554655A JP 2008554655 A JP2008554655 A JP 2008554655A JP 2009526795 A5 JP2009526795 A5 JP 2009526795A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
group
independently
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008554655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526795A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/001214 external-priority patent/WO2007093366A1/en
Publication of JP2009526795A publication Critical patent/JP2009526795A/ja
Publication of JP2009526795A5 publication Critical patent/JP2009526795A5/ja
Pending legal-status Critical Current

Links

JP2008554655A 2006-02-15 2007-02-13 新規なアミノアルコール置換アリールジヒドロイソキノリノン、それらの製造方法及び薬剤としてそれらの使用 Pending JP2009526795A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006007048 2006-02-15
PCT/EP2007/001214 WO2007093366A1 (en) 2006-02-15 2007-02-13 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments

Publications (2)

Publication Number Publication Date
JP2009526795A JP2009526795A (ja) 2009-07-23
JP2009526795A5 true JP2009526795A5 (https=) 2010-04-02

Family

ID=38169583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554655A Pending JP2009526795A (ja) 2006-02-15 2007-02-13 新規なアミノアルコール置換アリールジヒドロイソキノリノン、それらの製造方法及び薬剤としてそれらの使用

Country Status (16)

Country Link
US (1) US8501771B2 (https=)
EP (1) EP1987006B1 (https=)
JP (1) JP2009526795A (https=)
KR (1) KR20080094699A (https=)
CN (1) CN101384555A (https=)
AR (1) AR059522A1 (https=)
AT (1) ATE495157T1 (https=)
AU (1) AU2007214711A1 (https=)
BR (1) BRPI0707836A2 (https=)
CA (1) CA2636617A1 (https=)
DE (1) DE602007011897D1 (https=)
IL (1) IL193339A0 (https=)
MY (1) MY149854A (https=)
TW (1) TW200800907A (https=)
UY (1) UY30165A1 (https=)
WO (1) WO2007093366A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11008359B2 (en) 2002-08-23 2021-05-18 Illumina Cambridge Limited Labelled nucleotides
UA92083C2 (ru) * 2006-05-19 2010-09-27 Эбботт Леборетриз Азабициклические алкановые производные, замещенные конденсированным бициклогетероциклом
MX2008015662A (es) * 2006-06-08 2009-01-12 Lilly Co Eli Nuevos receptores antagonistas de la hormona concentradora de melanina (mch).
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9623021B2 (en) * 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
ES2475193T3 (es) 2007-01-22 2014-07-10 Gtx, Inc. Agentes de unión al receptor nuclear
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
JP2012505230A (ja) 2008-10-08 2012-03-01 ブリストル−マイヤーズ スクイブ カンパニー ピロロンメラニン凝集ホルモン受容体1拮抗薬
EP2558094A4 (en) * 2010-04-12 2013-09-25 Merck Sharp & Dohme pyridone derivatives
EP3159331A1 (en) 2010-05-05 2017-04-26 Infinity Pharmaceuticals, Inc. Tetrazolones as inhibitors of fatty acid synthase
US8450350B2 (en) 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
TW201215387A (en) * 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
HUE056957T2 (hu) 2014-08-29 2022-04-28 Chdi Foundation Inc Próbák huntingtin fehérjét megjelenítõ képalkotásra
WO2021028935A1 (en) * 2019-08-12 2021-02-18 Dr Reddy's Institute Of Life Sciences Heterocyclic compounds, and their use as allosteric modulators of 5-hydroxytryptamine 2c receptor (5-ht2cr)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10259176A (ja) * 1997-03-17 1998-09-29 Japan Tobacco Inc 血管新生阻害作用を有する新規アミド誘導体及びその用途
EP1218336A2 (en) 1999-09-20 2002-07-03 Takeda Chemical Industries, Ltd. Melanin concentrating hormone antagonist
WO2001072712A1 (en) 2000-03-24 2001-10-04 Cor Therapeutics, Inc. ISOQUINOLONE INHIBITORS OF FACTOR Xa
JP2004502423A (ja) 2000-07-05 2004-01-29 シナプティック・ファーマスーティカル・コーポレーション ヒトメラニン濃縮ホルモン受容体(mch1)をコードするdna及びその使用
EP1299362A4 (en) 2000-07-05 2004-11-03 Synaptic Pharma Corp SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
MXPA03000923A (es) 2000-07-31 2003-06-09 Smithkline Beecham Plc Compuestos de carboxamida y su uso como antagonistas de un receptor 11cby humano.
US20030022891A1 (en) 2000-12-01 2003-01-30 Anandan Palani MCH antagonists and their use in the treatment of obesity
ATE422887T1 (de) 2001-05-04 2009-03-15 Amgen Inc Kondensierte heterozyklische verbindungen
GB0124627D0 (en) 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
US7183415B2 (en) 2001-10-25 2007-02-27 Takeda Pharmaceutical Company Limited Quinoline compound
CA2468015A1 (en) 2001-11-27 2003-06-05 Merck & Co., Inc. 2-aminoquinoline compounds
CA2484233A1 (en) 2002-05-13 2003-11-27 Eli Lilly And Company Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
DE10238865A1 (de) 2002-08-24 2004-03-11 Boehringer Ingelheim International Gmbh Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US20060194871A1 (en) * 2003-04-11 2006-08-31 Barvian Kevin K Heterocyclic mchr1 antagoists
US7390820B2 (en) 2003-08-25 2008-06-24 Amgen Inc. Substituted quinolinone derivatives and methods of use
US20070078125A1 (en) * 2003-10-23 2007-04-05 Glaxo Group Limited Arylamine mch r1 antagonists
WO2005047293A1 (en) 2003-11-07 2005-05-26 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
UA83416C2 (en) * 2004-02-13 2008-07-10 Баниу Фармасьютикал Ко., Лтд. Fused ring 4-oxopyrimidine derivative
US20050256124A1 (en) 2004-04-15 2005-11-17 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto

Similar Documents

Publication Publication Date Title
JP2009526795A5 (https=)
JP2009526793A5 (https=)
JP2009526792A5 (https=)
RU2008136898A (ru) Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств
JP2009526794A5 (https=)
JP6259855B2 (ja) インフルエンザウイルス複製の阻害剤
ES2572803T3 (es) Estimuladores de GCs
TWI852872B (zh) 三環性螺化合物之用途
JP6557674B2 (ja) 新規クラスのミュー−オピオイド受容体アゴニスト
JP2021527638A (ja) B型肝炎カプシドアセンブリモジュレーター
ES2573715T3 (es) Ligandos sigma para la prevención y/o el tratamiento del vómito inducido por la quimioterapia o la radioterapia
JP2006501202A5 (https=)
JP2006517563A5 (https=)
CN102812006A (zh) 新型抗疟疾试剂
CN101454299A (zh) 酰脲衍生物及其医药用途
DK3083592T3 (en) SUBSTITU
AU2021200164A1 (en) Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AU2009310807B2 (en) Cyclohexane derivative and pharmaceutical use thereof
US9624198B2 (en) Substituted piperidinyltetrahydroquinolines
ES2995040T3 (en) Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
TW201605433A (zh) NSAID與西克馬(sigma)受體配位體之組合
JP2008531679A (ja) オキシトシンアンタゴニストとしての1,2,4−トリアゾール誘導体とその使用
CA2934134A1 (en) Substituted bipiperidinyl derivatives as adrenoreceptor alpha 2c antagonists
JP2018016544A (ja) 新規ジアザビシクロ[2.2.2]オクタン誘導体
TW200302097A (en) Lactams as tachykinin antagonists